Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Atavistik Bio, Inc
Centre Oscar Lambret
Abramson Cancer Center at Penn Medicine
Pfizer
AstraZeneca
M.D. Anderson Cancer Center
Duke University
AstraZeneca
Genmab
Dana-Farber Cancer Institute
University of Miami
University of Tennessee Graduate School of Medicine
Asan Medical Center
DL Analytics
Imperial College London
Dana-Farber Cancer Institute
University of Alabama at Birmingham
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yuri Semenyuk Rivne Regional Clinical Hospital
Washington University School of Medicine
City of Hope Medical Center
University Health Network, Toronto
Assiut University
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Stanford University
University of Virginia
M.D. Anderson Cancer Center
University of California, San Diego
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Washington University School of Medicine
PinkDx, Inc.
Washington University School of Medicine
Northwell Health
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jonsson Comprehensive Cancer Center
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Gradalis, Inc.
University of Alabama at Birmingham
Aesculap AG
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Abramson Cancer Center at Penn Medicine
University of Alabama at Birmingham
Northwestern University